Skip to main content
Clinical Trials/IRCT20220901055844N1
IRCT20220901055844N1
Recruiting
Phase 3

A comparative study of the therapeutic effect of topical finasteride with oral finasteride in patients with androgenetic alopecia .

Shiraz University of Medical Sciences0 sites28 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Shiraz University of Medical Sciences
Enrollment
28
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Having androgenic alopecia grade 2 to 5 based on the Norwood Hamilton classification in men
  • Age above 18 years
  • Not receiving treatment for androgenic alopecia during the last 3 months
  • Having androgenetic alopecia grade 2 to 3 according to Ludwig grading in women
  • Menopausal women or women over 18 years of age who use IUD or TL.
  • Informed consent to participate in the study

Exclusion Criteria

  • Failure to sign the consent form.
  • History of allergic reaction and anaphylaxis to Finasteride drug
  • Pregnancy or trying to have a child.
  • Individual history of infertility
  • Active infection or any scratches and wounds in the scalp

Outcomes

Primary Outcomes

Not specified

Similar Trials